Amit Oza, M.D.
Princess Margaret Cancer Centre · Princess Margaret Cancer Centre/University Health Network
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amit Oza, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06328491 · Erdafitinib in Metastatic Steroid-cell Ovarian CancerUniversity Health Network, Toronto · completed · Ovarian Cancer, Steroid Cell Tumor, Malignant · principal investigator
- N/ANCT06254781 · Luspatercept in Metastatic AGCT of the OvaryUniversity Health Network, Toronto · completed · Adult Granulosa Cell Tumor of the Ovary · principal investigator
- N/ANCT03420118 · Study of Biomarkers in Gynecological CancersUniversity Health Network, Toronto · recruiting · Gynecologic Cancer · principal investigator
- N/ANCT03419689 · Study Looking at Biomarkers in Ovarian CancerUniversity Health Network, Toronto · recruiting · Gynecologic Cancer · principal investigator
- Ph2NCT03029403 · Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube CancerUniversity Health Network, Toronto · active not recruiting · Advanced Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma · principal investigator
- N/ANCT02952521 · Ovarian Tumor Biopsies to Study Response to TreatmentsUniversity Health Network, Toronto · completed · Epithelial Ovarian Cancer · principal investigator
- N/ANCT02681237 · A Study of Cediranib and Olaparib at Disease Worsening in Ovarian CancerUniversity Health Network, Toronto · completed · Ovarian Cancer · principal investigator
- Ph2NCT02489006 · A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube CancerUniversity Health Network, Toronto · active not recruiting · Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant Treatment · principal investigator
- N/ANCT02489058 · A Study of Long-Term Responders on OlaparibUniversity Health Network, Toronto · completed · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer · principal investigator
- Ph2NCT02340611 · A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on OlaparibUniversity Health Network, Toronto · completed · Ovarian Cancer · principal investigator
- Ph2NCT01914510 · A Study of ENMD-2076 in Ovarian Clear Cell CancersUniversity Health Network, Toronto · completed · Ovarian Clear Cell Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 10 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.